InvestorsHub Logo
Followers 96
Posts 2744
Boards Moderated 0
Alias Born 09/15/2020

Re: None

Friday, 11/11/2022 6:04:08 PM

Friday, November 11, 2022 6:04:08 PM

Post# of 700210
Some observations for my one daily post:

Why is the name change done for this conference? It seems to me that they could have continued to use DCVax-L until it became important to change it. It would avoid any confusion the name change could potentially create. One reason could be that the JA uses that name and they needed to use it here in order to not create any confusion when publication hits. JMHO

I have mentioned before that I didn’t see any huge upward movement prior to news. I think that is still the case as the shorts are continuing to cover (I think they are covering but not returning the shares, being willing to pay the interest rate for the chance to use the shares to suppress and for daily shorting). JMHO

Murcidencel will not be the commercial name, but is the generic name they have gotten approved. JMHO

I think that they are and have been in constant communication with MHRA and FDA and that in both jurisdictions there’s a rolling submission going on as we speak. JMHO

Finally, I think that the appearance of the 10 new authors is a good sign that the JA is not far out in the future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News